News

Cooperation between the Nencki Institute and the MEK2 Research Foundation

The Nencki Institute of the Polish Academy of Sciences has established a research collaboration with the MEK2 Research Foundation, an organization uniting families of patients affected by ultra-rare progressive cardiofaciocutaneous syndrome type 4 (CFC4), a condition impacting the heart, brain, skin, and overall development, for which there is currently no known treatment. This disease is caused by a mutation in the MAP2K2 gene (also known as MEK2) and belongs to a group of disorders known ...